Case-Based Review

Primary Brain Tumors


 

Series Editor: Arthur T. Skarin, MD, FACP, FCCP

Primary central nervous system tumors are relatively rare, but they can cause significant morbidity. They are also among the most lethal of all neoplasms. Brain tumors are the second most common cause of death due to intracranial disease, second only to stroke. The estimated annual incidence of primary brain tumors is approximately 21 per 100,000 individuals in the United States. The incidence of brain tumors varies by gender, age, race, ethnicity, and geography and has increased over time. Gliomas and germ cell tumors are more common in men, whereas meningiomas are twice as common in women. The only validated environmental risk factor for primary brain tumors is exposure to ionizing radiation.

To read the full article in PDF:

Click here

Recommended Reading

Good survival rates with temozolomide CRT for high-risk, low-grade gliomas
MDedge Hematology and Oncology
Lung cancer diagnosis aided by novel plasma protein
MDedge Hematology and Oncology
Cranial radiotherapy for acute lymphoblastic leukemia linked to impaired neurocognition
MDedge Hematology and Oncology
Spare the hippocampus, preserve the memory in whole brain irradiation
MDedge Hematology and Oncology
Study indicates potential for longer survival after radiosurgery for brain metastases
MDedge Hematology and Oncology
Younger adults with brain metastases survive longer with radiosurgery alone
MDedge Hematology and Oncology
CENTRIC results signal end of cilenglitide in glioblastoma
MDedge Hematology and Oncology
Gene panel identifies residual neuroblastoma metastases
MDedge Hematology and Oncology
New chemo regimen is active against recalcitrant neuroendocrine tumors
MDedge Hematology and Oncology
Bevacizumab fails to improve survival in newly diagnosed glioblastoma
MDedge Hematology and Oncology